Trial Profile
Incretin-based therapy in non-symptomatic, early diagnosed type 1 diabetics
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jan 2022
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms LiraT1D10-30
- 07 Jan 2022 Status changed from recruiting to completed.
- 25 Jan 2016 New trial record